In a randomized, double-blind study, liraglutide was found to be more effective than a placebo group for weight loss in obese adults with type 2 diabetes
Wegovy is now the first weight loss medication to also be approved to help prevent life-threatening cardiovascular events in adults with cardiovascular disease and either obesity or overweight, John Sharretts, M.D., director of the Division of Diabetes, Lipid Disorders, and Obesity in the FDAs Center for Drug Evaluation and Research, said in a statement
Here is how to think through the why, how, and which of this choice
British Journal of Pharmacology , 179 (4), 625-641
It is designed to deliver both brightening / glow effects (via glutathione) and firming / elasticity / texture improvements (via multiple peptides) while providing hydration